abstract |
An immunogenic composition comprising S. pneumoniae capsular saccharide conjugates derived from serotypes 19A and 19F, wherein 19A is conjugated to a first bacterial toxoid and 19F is conjugated to a second bacterial toxoid Providing things. S. pneumoniae capsules derived from serotypes 19A and 19F, wherein 19A is conjugated to a first bacterial toxoid such as pneumolysin and 19F is conjugated to a second bacterial toxoid such as diphtheria toxoid An immunogenic composition comprising a saccharide conjugate, and a vaccine for preventing pneumococcal infection in infants and the elderly comprising the immunogenic composition and for eliciting an improved immune response against otitis media. [Selection figure] None |